These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11054258)

  • 1. Live attenuated HIV vaccines: a proposal for further research and development.
    Mills J; Desrosiers R; Rud E; Almond N
    AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1453-61. PubMed ID: 11054258
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for live attenuated HIV.
    Desrosiers RC
    Nat Med; 1998 Sep; 4(9):982. PubMed ID: 9734368
    [No Abstract]   [Full Text] [Related]  

  • 3. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
    Das AT; Zhou X; Vink M; Klaver B; Berkhout B
    Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.
    Desrosiers RC
    J Int Assoc Physicians AIDS Care; 1998 Nov; 4(11):22-3. PubMed ID: 11366120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perspectives for the development of preventive vaccines against HIV/AIDS].
    Esparza J
    Medicina (B Aires); 1998; 58 Suppl 1():57-63. PubMed ID: 9674249
    [No Abstract]   [Full Text] [Related]  

  • 6. Human trials of experimental HIV vaccines.
    Burke DS
    AIDS; 1995; 9 Suppl A():S171-80. PubMed ID: 8819583
    [No Abstract]   [Full Text] [Related]  

  • 7. [An update and the outlook in vaccination against HIV/AIDS].
    Ivan A; Azoicăi D; Mitroi I
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(1-2):207-10. PubMed ID: 1823419
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group.
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):221-2. PubMed ID: 8198875
    [No Abstract]   [Full Text] [Related]  

  • 9. Attenuated retrovirus vaccines and AIDS.
    Marx PA
    Science; 1995 Nov; 270(5239):1219-20; author reply 1220-2. PubMed ID: 7502054
    [No Abstract]   [Full Text] [Related]  

  • 10. A scientific overview of the development of AIDS vaccines.
    Little K; Surjadi M
    J Assoc Nurses AIDS Care; 2000; 11(6):19-28. PubMed ID: 11082799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus.
    Ensoli B; Cafaro A
    AIDS Clin Rev; 2000-2001; ():23-61. PubMed ID: 10999215
    [No Abstract]   [Full Text] [Related]  

  • 13. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives for a protective HIV-1 vaccine.
    Schiavone M; Quinto I; Scala G
    Adv Pharmacol; 2008; 56():423-52. PubMed ID: 18086420
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development of a vaccine against HIV: is this aim accomplishable?].
    Wagner R; Asbach B
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
    [No Abstract]   [Full Text] [Related]  

  • 17. State of the science. HIV vaccine development.
    Grady C; Kelly G
    Nurs Clin North Am; 1996 Mar; 31(1):25-39. PubMed ID: 8604385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges and opportunities for development of an AIDS vaccine.
    Nabel GJ
    Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.